Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001013762-23-001579
Filing Date
2023-10-04
Accepted
2023-10-04 16:07:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea186263-defa14a_tffpharma.htm DEFA14A 21526
2 GRAPHIC image_001.jpg GRAPHIC 21423
  Complete submission text file 0001013762-23-001579.txt   52123
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

EIN.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39102 | Film No.: 231307955
SIC: 2834 Pharmaceutical Preparations